VLON - Vallon Pharmaceuticals Inc
Previous close
360
0 0%
Share volume: 1,237
Last Updated: Fri 21 Apr 2023 06:00:00 AM CEST
Pharmaceutical Preparation Manufacturing :
-2.88%
PREVIOUS CLOSE
CHG
CHG%
$360.00
0.00
0.00%
Fundamental analysis
57%
Profitability
68%
Dept financing
0%
Liquidity
0%
Performance
75%
Performance
5 Days
10.50%
1 Month
-2.44%
3 Months
39.13%
6 Months
24.22%
1 Year
-82.38%
2 Year
-91.09%
Key data
Stock price
$360.00
DAY RANGE
N/A - $360.00
52 WEEK RANGE
$184.86 - $1,953.00
52 WEEK CHANGE
-$0.82
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
Company detail
CEO:
Region: US
Website: www.vallon-pharma.com
Employees: 2
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Preparation Manufacturing
Sector: Manufacturing
Region: US
Website: www.vallon-pharma.com
Employees: 2
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Preparation Manufacturing
Sector: Manufacturing
Vallon Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company, headquartered in Philadelphia, PA. The Company is focused on the development of new medications to help patients with central nervous system (CNS) disorders. The Company’s lead investigational product candidate, ADAIR, is a novel abuse deterrent formulation of amphetamine immediate release being developed for the treatment of ADHD and narcolepsy.
Recent news